Nafamostat mesylate is a broad-spectrum synthetic serine protease inhibitor used as a pharmaceutical raw material. It functions by inhibiting various proteases involved in coagulation and inflammation, and has been investigated for its potential antiviral activity against influenza and coronavirus.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 82956-11-4
Camostat mesylate
pharmaceutical raw material
Ampyrone
pharmaceutical raw material
Phenindione
pharmaceutical raw material
4-acetaminoantipyrine
pharmaceutical raw material
Methylprednisolone
pharmaceutical raw material
(6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate;methanesulfonic acid
SRXKIZXIRHMPFW-UHFFFAOYSA-N
CS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N